Expert insights. Personalized for you.
Monopar Therapeutics Reports Third Quarter 2021 Financial Results and Recent Clinical Developments Monopar Therapeutics Reports Third Quarter 2021 Financial Results and Recent Clinical Developments First Patients Dosed in Camsirubicin Phase 1b Clinical Trial in U.S.Validive® Phase 2b/3 VOICE Trial Cleared … Continue reading → GlobeNewswire MORE
Trial design and other details are being evaluated and a comprehensive update on the overall Novartis SMA clinical development program will be provided at a future time following further discussions with health authorities. MORE
Brii Biosciences Provides Update on Strategic Clinical Development Progress Brii Biosciences Provides Update on Strategic Clinical Development Progress Company received U.S. MORE
Press Release 30 September 2020 Immunicum AB Announces Update on Corporate and Clinical Development Strategy Immunicum AB (publ: IMMU.ST) announced today an update on the Company’s corporate and clinical development strategy. The strategy will be presented by members of the … Continue reading → GlobeNewswire MORE
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience Bernard Coulie, M.D., MORE
The post Vectura Signs Pre-Clinical Development Agreement with Incannex to Advance IHL-216A for the Treatment of Traumatic Brain Injury appeared first on Pharma Mirror Magazine. MORE
Clinical DevelopmentAccording to the pharma firm, Saphnelo (anifrolumab) combined with standard therapy resulted in reduction of systemic lupus erythematosus disease activity. MORE
Clinical-stage biopharmaceutical firm ESCAPE Bio has snagged a $73 million crossover financing deal, led by Wellington Management Company, which will help advance the company’s two clinical development programs of precision neurology medicines for patients with genetic neurodegeneration MORE
have received the green light from Health Canada for their Clinical Trial Application for VCTX210: an allogeneic, gene-edited, immune-evasive, stem cell-derived therapy for the treatment of type 1 diabetes (T1D). Clinical DevelopmentCRISPR Therapeutics and ViaCyte, Inc. MORE
Medsenic Partners With Phebra for the Clinical Development of the Oral Form of Arscimed® for the Treatment of Autoimmune Diseases Medsenic Partners With Phebra for the Clinical Development of the Oral Form of Arscimed® for the Treatment of Autoimmune Diseases … Continue reading → Business Wire MORE
EpiEndo Pharmaceuticals Secures EUR 20 Million Series A Funding to Advance Clinical Development of its Non-Antibiotic Macrolide for the treatment of COPD EpiEndo Pharmaceuticals Secures EUR 20 Million Series A Funding to Advance Clinical Development of its Non-Antibiotic Macrolide for … Continue reading → Business Wire MORE
ObsEva To Present Data on Two Clinical Development Programs at ESHRE Virtual 37th Annual Meeting ObsEva To Present Data on Two Clinical Development Programs at ESHRE Virtual 37th Annual Meeting – Data from Phase 3 study of Yselty® (linzagolix) … Continue reading → GlobeNewswire MORE
Tubulis appoints Günter Fingerle-Rowson as Chief Medical Officer to lead the clinical development of its new generation of ADCs Tubulis appoints Günter Fingerle-Rowson as Chief Medical Officer to lead the clinical development of its new generation of ADCs MUNICH–(BUSINESS WIRE)–Tubulis … Continue reading → Business Wire MORE
Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Key leadership appointment of Dr. Morriss enhances the company’s research … Continue reading → Business Wire MORE
Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided an update on its COVID-19 vaccine program. Novavax completed enrollment of 15,000 participants in a pivotal Phase 3 clinical trial being conducted in the U.K. MORE
Saniona Updates Tesomet Clinical Development Timelines Based on Manufacturing Feedback from U.S. FDA Saniona Updates Tesomet Clinical Development Timelines Based on Manufacturing Feedback from U.S. FDA PRESS RELEASE April 22, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused … Continue reading → GlobeNewswire MORE
AlgoTherapeutix recently raised a 12M€ Series A that will fund the Phase 1 and 2 clinical development of ATX01. Their lead programme ATX01 is in clinical development in Chemotherapy-Induced Peripheral Neuropathy. 15, 2020 07:15 UTC. MORE
Samsung Biologics and Enzolytics have entered into a strategic CDMO partnership agreement targeting monoclonal antibody production. Upstream Processing MORE
Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma. Clinical Development MORE
AB Science receives FDA authorization to start clinical development program of masitinib in mast cell activation syndrome (MCAS) AB Science receives FDA authorization to start clinical development program of masitinib in mast cell activation syndrome (MCAS) PRESS RELEASE AB SCIENCE … Continue reading → GlobeNewswire MORE
Shares of Adverum Biotechnologies plunged more than 20% in premarket trading after the company announced it was revising its clinical development plan for investigational gene therapy candidate ADVM-022 based on safety concerns in patients with diabetic macular edema (DME MORE
AsclepiX appoints Dr. Amir Shojaei as Chief Scientific Officer and Executive Vice President, Clinical Development AsclepiX appoints Dr. Amir Shojaei as Chief Scientific Officer and Executive Vice President, Clinical Development Shojaei brings over two and a half decades of experience in clinical pharmaceutical development BALTIMORE, Oct. MORE
Alzheon Appoints Adem Albayrak as Head of Operations and Earvin Liang, PhD, as Vice President of Clinical Development Alzheon Appoints Adem Albayrak as Head of Operations and Earvin Liang, PhD, as Vice President of Clinical Development New Hires Bring Extensive … Continue reading → Business Wire MORE
ALX Oncology Reports Third Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights ALX Oncology Reports Third Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights SOUTH SAN FRANCISCO, Calif., MORE
Allarity Therapeutics and Lantern Pharma Enter into Agreement for Future Clinical Development of Irofulven Allarity Therapeutics and Lantern Pharma Enter into Agreement for Future Clinical Development of Irofulven Lantern will reacquire global rights to Irofulven and assume full authority to … Continue reading → GlobeNewswire MORE
Given all the uncertainties of fill and finish in clinical development, one thing is certain – there is little room for failure, and rarely a second chance MORE
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by an inflammatory polyarthritis that preferentiallyaffects the small joints. RA is… Current features Volume 12 Issue 6 MORE
Fractyl Announces Closing of $100 Million Series F Financing to Expand Clinical Development Programs in Type 2 Diabetes Fractyl Announces Closing of $100 Million Series F Financing to Expand Clinical Development Programs in Type 2 Diabetes – Financing will support … Continue reading → Business Wire MORE
Moderna Provides Updates on the Clinical Development and Production of Its COVID-19 Vaccine Candidate Moderna Provides Updates on the Clinical Development and Production of Its COVID-19 Vaccine Candidate Interim durability data from NIH-led Phase 1 study of mRNA-1273 published as … Continue reading → Business Wire MORE
ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments EVANSTON, Ill.–(BUSINESS MORE
Valbiotis Announces That It Has Submitted to the Competent Authorities the Three Clinical Protocols for TOTUM•854 Indicated in the Reduction of Blood Pressure and Presents Its Comprehensive Clinical Development Plan Valbiotis Announces That It Has Submitted to the Competent Authorities … Continue reading → Business Wire MORE
Clinical Development Related Topics Bio Pharma Dive
FEBRUARY 1, 2021
Given all the uncertainties of fill and finish in clinical development, one thing is certain – there is little room for failure, and rarely a second chance
Journal for Clinical Studies
DECEMBER 8, 2020
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by an inflammatory polyarthritis that preferentiallyaffects the small joints. RA is… Current features Volume 12 Issue 6
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioPharma Reporter
OCTOBER 11, 2021
Samsung Biologics and Enzolytics have entered into a strategic CDMO partnership agreement targeting monoclonal antibody production. Upstream Processing
BioSpace
JULY 22, 2021
Shares of Adverum Biotechnologies plunged more than 20% in premarket trading after the company announced it was revising its clinical development plan for investigational gene therapy candidate ADVM-022 based on safety concerns in patients with diabetic macular edema (DME
BioTech 365
NOVEMBER 10, 2021
BioTech 365
MAY 17, 2021
Brii Biosciences Provides Update on Strategic Clinical Development Progress Brii Biosciences Provides Update on Strategic Clinical Development Progress Company received U.S.
BioTech 365
SEPTEMBER 29, 2021
BioTech 365
NOVEMBER 11, 2021
ALX Oncology Reports Third Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights ALX Oncology Reports Third Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights SOUTH SAN FRANCISCO, Calif.,
BioTech 365
DECEMBER 15, 2020
BioTech 365
AUGUST 31, 2021
BioTech 365
AUGUST 17, 2021
ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments EVANSTON, Ill.–(BUSINESS
The Pharma Data
NOVEMBER 30, 2020
Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided an update on its COVID-19 vaccine program. Novavax completed enrollment of 15,000 participants in a pivotal Phase 3 clinical trial being conducted in the U.K.
BioTech 365
AUGUST 10, 2021
|
BioTech 365
JULY 29, 2021
BioTech 365
JULY 13, 2021
Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Key leadership appointment of Dr. Morriss enhances the company’s research … Continue reading → Business Wire
BioTech 365
JULY 1, 2021
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience Bernard Coulie, M.D.,
BioTech 365
OCTOBER 8, 2021
AsclepiX appoints Dr. Amir Shojaei as Chief Scientific Officer and Executive Vice President, Clinical Development AsclepiX appoints Dr. Amir Shojaei as Chief Scientific Officer and Executive Vice President, Clinical Development Shojaei brings over two and a half decades of experience in clinical pharmaceutical development BALTIMORE, Oct.
BioSpace
SEPTEMBER 14, 2020
Clinical-stage biopharmaceutical firm ESCAPE Bio has snagged a $73 million crossover financing deal, led by Wellington Management Company, which will help advance the company’s two clinical development programs of precision neurology medicines for patients with genetic neurodegeneration
BioTech 365
SEPTEMBER 13, 2021
Alzheon Appoints Adem Albayrak as Head of Operations and Earvin Liang, PhD, as Vice President of Clinical Development Alzheon Appoints Adem Albayrak as Head of Operations and Earvin Liang, PhD, as Vice President of Clinical Development New Hires Bring Extensive … Continue reading → Business Wire
The Pharma Data
DECEMBER 14, 2020
AlgoTherapeutix recently raised a 12M€ Series A that will fund the Phase 1 and 2 clinical development of ATX01. Their lead programme ATX01 is in clinical development in Chemotherapy-Induced Peripheral Neuropathy. 15, 2020 07:15 UTC.
BioTech 365
MARCH 25, 2021
BioTech 365
NOVEMBER 30, 2021
Valbiotis Announces That It Has Submitted to the Competent Authorities the Three Clinical Protocols for TOTUM•854 Indicated in the Reduction of Blood Pressure and Presents Its Comprehensive Clinical Development Plan Valbiotis Announces That It Has Submitted to the Competent Authorities … Continue reading → Business Wire
BioTech 365
FEBRUARY 24, 2021
Outsourcing Pharma
OCTOBER 26, 2021
Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma. Clinical Development
BioTech 365
SEPTEMBER 30, 2020
Press Release 30 September 2020 Immunicum AB Announces Update on Corporate and Clinical Development Strategy Immunicum AB (publ: IMMU.ST) announced today an update on the Company’s corporate and clinical development strategy. The strategy will be presented by members of the … Continue reading → GlobeNewswire
BioPharma Reporter
NOVEMBER 16, 2021
have received the green light from Health Canada for their Clinical Trial Application for VCTX210: an allogeneic, gene-edited, immune-evasive, stem cell-derived therapy for the treatment of type 1 diabetes (T1D). Clinical DevelopmentCRISPR Therapeutics and ViaCyte, Inc.
BioTech 365
JUNE 30, 2021
Medsenic Partners With Phebra for the Clinical Development of the Oral Form of Arscimed® for the Treatment of Autoimmune Diseases Medsenic Partners With Phebra for the Clinical Development of the Oral Form of Arscimed® for the Treatment of Autoimmune Diseases … Continue reading → Business Wire
BioTech 365
JULY 26, 2021
Allarity Therapeutics and Lantern Pharma Enter into Agreement for Future Clinical Development of Irofulven Allarity Therapeutics and Lantern Pharma Enter into Agreement for Future Clinical Development of Irofulven Lantern will reacquire global rights to Irofulven and assume full authority to … Continue reading → GlobeNewswire
BioTech 365
JUNE 16, 2021
Fractyl Announces Closing of $100 Million Series F Financing to Expand Clinical Development Programs in Type 2 Diabetes Fractyl Announces Closing of $100 Million Series F Financing to Expand Clinical Development Programs in Type 2 Diabetes – Financing will support … Continue reading → Business Wire
BioTech 365
DECEMBER 3, 2020
Moderna Provides Updates on the Clinical Development and Production of Its COVID-19 Vaccine Candidate Moderna Provides Updates on the Clinical Development and Production of Its COVID-19 Vaccine Candidate Interim durability data from NIH-led Phase 1 study of mRNA-1273 published as … Continue reading → Business Wire
BioTech 365
OCTOBER 4, 2021
AB Science receives FDA authorization to start clinical development program of masitinib in mast cell activation syndrome (MCAS) AB Science receives FDA authorization to start clinical development program of masitinib in mast cell activation syndrome (MCAS) PRESS RELEASE AB SCIENCE … Continue reading → GlobeNewswire
BioTech 365
JUNE 23, 2021
ObsEva To Present Data on Two Clinical Development Programs at ESHRE Virtual 37th Annual Meeting ObsEva To Present Data on Two Clinical Development Programs at ESHRE Virtual 37th Annual Meeting – Data from Phase 3 study of Yselty® (linzagolix) … Continue reading → GlobeNewswire
The Pharma Data
SEPTEMBER 22, 2020
Trial design and other details are being evaluated and a comprehensive update on the overall Novartis SMA clinical development program will be provided at a future time following further discussions with health authorities.
BioTech 365
APRIL 20, 2021
Tubulis appoints Günter Fingerle-Rowson as Chief Medical Officer to lead the clinical development of its new generation of ADCs Tubulis appoints Günter Fingerle-Rowson as Chief Medical Officer to lead the clinical development of its new generation of ADCs MUNICH–(BUSINESS WIRE)–Tubulis … Continue reading → Business Wire
Pharma Mirror
JUNE 23, 2021
The post Vectura Signs Pre-Clinical Development Agreement with Incannex to Advance IHL-216A for the Treatment of Traumatic Brain Injury appeared first on Pharma Mirror Magazine.
BioTech 365
AUGUST 17, 2021
EpiEndo Pharmaceuticals Secures EUR 20 Million Series A Funding to Advance Clinical Development of its Non-Antibiotic Macrolide for the treatment of COPD EpiEndo Pharmaceuticals Secures EUR 20 Million Series A Funding to Advance Clinical Development of its Non-Antibiotic Macrolide for … Continue reading → Business Wire
Outsourcing Pharma
NOVEMBER 16, 2021
Clinical DevelopmentAccording to the pharma firm, Saphnelo (anifrolumab) combined with standard therapy resulted in reduction of systemic lupus erythematosus disease activity.
BioTech 365
APRIL 21, 2021
Saniona Updates Tesomet Clinical Development Timelines Based on Manufacturing Feedback from U.S. FDA Saniona Updates Tesomet Clinical Development Timelines Based on Manufacturing Feedback from U.S. FDA PRESS RELEASE April 22, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused … Continue reading → GlobeNewswire
40 
Let's personalize your content